Shares of Spire Healthcare Group plc (LON:SPI – Get Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 200.78 and traded as high as GBX 218. Spire Healthcare Group shares last traded at GBX 218, with a volume of 978,499 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 245 price target on shares of Spire Healthcare Group in a report on Friday, May 15th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Spire Healthcare Group currently has an average rating of “Buy” and a consensus price target of GBX 276.
Get Our Latest Stock Analysis on Spire Healthcare Group
Spire Healthcare Group Stock Down 0.6%
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Read More
- Five stocks we like better than Spire Healthcare Group
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
